Quick Search

 

 


 

 

Result Summary for S3AP48

Result Summary
Protocol ID: S3AP48
Clinical Study ID: S3AP48
Official Title: A Pilot Study to Determine the Safety and Efficacy of Ondansetron (GR38032F) in the Prevention of Nausea and Vomiting Induced by Cancer Chemotherapy Regimens Containing Cisplatin, Carboplatin or Doxorubicin in Combination with either Cyclophosphamide or Ifosfamide in Children
Phase: Phase 1
Study Indications or Diseases:
  • Nausea and Vomiting
Generic Name: ondansetron
Trade/Product Name: zofran;zofran
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.